How should I use VOXZOGO(Vosoritide)?

The dosage of VOXZOGO is determined by the patient’s actual body weight and is administered as a daily subcutaneous injection.

Individualized Weight-Based Dosing Regimen

VOXZOGO (vosoritide) is administered subcutaneously once daily, with the dose precisely calculated based on the patient’s current body weight. The recommended dosage and injection volume are outlined in a standardized dosing table, with adjustments made as the patient’s weight changes. The drug is supplied in single-use vials of varying strengths (0.4 mg, 0.56 mg, 1.2 mg), and must be reconstituted prior to administration. Growth and weight should be monitored every 3–6 months to ensure appropriate dosing. VOXZOGO should be discontinued upon closure of the epiphyses. Dosage for other populations is not specified in the description.